HUMA Investors Have Opportunity to Lead Humacyte, Inc. Securities Fraud Lawsuit

LOS ANGELES, Dec. 16, 2024 /PRNewswire/ — The Law Offices of Frank R. Cruz announces that investors with substantial losses have opportunity to lead the securities fraud class action lawsuit against Humacyte, Inc. (“Humacyte” or the “Company”) (NASDAQ: HUMA). Class Period: May 10, 2024 –…